This message was sent to ##Email##
|
|
|
|
|
Medical News Today
Scientists are hopeful that a new type of skin patch could replace needles as a method of flu vaccination. When they tested the skin patch on mice, it elicited an appropriate immune response without side effects.
READ MORE
Infection Control Today
An isolation strategy of contact precautions in multiple-bed rooms was non-inferior to contact precautions in a single-bed room for preventing transmission of ESBL-producing Enterobacteriaceae, a recent study found. “Noninferiority of the multiple-bed room strategy might change the current single-bed room preference for isolation of patients with ESBL-producing Enterobacteriaceae and, thus, broaden infection-control options for ESBL-producing Enterobacteriaceae in daily clinical practice,” wrote Dr. Marjolein F. Q. Kluytmans-van den Bergh, Ph.D., with the Department of Infection Control at Amphia Hospital in Breda, Netherlands, in a recent Lancet Infectious Diseases article.
READ MORE
|
Promoted by
|
|
|
|
 |
University of Texas Health Science Center at Houston via ScienceDaily
Researchers reported that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.
READ MORE
 |
|
With instrument-specific product configurations, tailor-made to your specific analyzer to maximize AMR coverage, automatic scheduling and shipping, and live, same-day technical support, you'll spend little time worrying about preparing, testing and ordering materials.
Visit www.mainestandards.com/YES or call 1-800-377-9684 to learn more.
|
|
University of Kentucky via Medical Xpress
Decades of research and treatment advances have helped extend the lives of many people living with HIV, but while these patients live longer, their risk of developing dangerous blood clots increases as much as tenfold. Blood clots — also known as thrombi — can wreak havoc on the body, causing events such as debilitating strokes and heart attacks.
READ MORE
Contagion Live
It’s no secret that Ebola is a highly pathogenic and deadly disease. In the ongoing Ebola outbreak in the Democratic Republic of the Congo, the bloodborne virus has an overall case fatality ratio of 67%. Although the risk of death during acute infection phase is common knowledge, information on subsequent mortality after recovery has been widely unknown, until now.
READ MORE
|
|
The Science Times
A team of researchers from the University of British Columbia in close partnership with the Provincial Health Services Authority Therapeutic Evaluation Unit recently released the results of their study in the Journal of American College of Cardiology. The team found that the patients who have been prescribed with fluoroquinolone antibiotics, such as ciproflaxacin also known as Cipro, are at higher risk of developing mitral regurgitation.
READ MORE
American Medical Technologists
Enhance your credentials to work in the rapidly expanding field of molecular diagnostics.
READ MORE
|
The Light Diagnostics™ Collection provides an abundance of immunofluorescence staining reagents specific to human disease-causing agents.
Recognized by clinical diagnostic and investigative labs as one of the leading brands in immunofluorescence technology, these IVD products have 20 years of expertise behind them to light your way.
|
|
|
|
|
|
The miniiSED™ is the newest addition to the iSED™ family of ESR analyzers from ALCOR Scientific. The miniiSED™ is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED™ is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
Learn more
|
|
|
|
|
The Duke Chronicle
The key to better health could be solved by taking a closer look at who distributes antibiotics, according to a recent Duke study. The study was conducted in four community hospitals across North Carolina and tested the feasibility of two strategies in lowering the rates of antibiotic overprescription, a major cause of the development of multidrug-resistant superbugs. The national implementation of these antimicrobial strategies could have wide-ranging benefits.
READ MORE
Johns Hopkins via ScienceDaily
In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.
A report on the research, published Sept. 16 in the journal Brain, details the new approach, which selectively circumvents the immune response against foreign cells, allowing transplanted cells to survive, thrive and protect brain tissue long after stopping immune-suppressing drugs.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, contact Andy Keith at 972-402-7707.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
National Institutes of Health via Infection Control Today
Scientists using an experimental treatment have slowed the progression of scrapie, a degenerative central nervous disease caused by prions, in laboratory mice and greatly extended the rodents’ lives, according to a new report in JCI Insight. The scientists used antisense oligonucleotides, synthetic compounds that inhibit the formation of specific proteins.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
